EPA vs. DHA: Fish Oil and Treatment-Resistant Depression
From Psychopharmacology and Psychiatry Updates · · 12 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
In this episode, we explore whether EPA, a specific omega-3 fatty acid, can help patients with treatment-resistant depression. Dr. Derick Vergne breaks down the clinical evidence, dosing, and the anti-inflammatory mechanisms that may explain why EPA outperforms DHA in easing stubborn depressive symptoms.
Faculty: Derick E. Vergne, M.D. Host: Richard Seeber, M.D.
- Learn more about our memberships here
- Earn 0.75 CMEs: Quick Take Vol. 84
- Eicosapentaenoic Acid: Effective as Adjunctive for TRD?
Back to Psychopharmacology and Psychiatry Updates · Report a problem